Literature DB >> 15368276

Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control.

Anna Vossenkämper1, Daniela Struck, Cosme Alvarado-Esquivel, Tobias Went, Kioyshi Takeda, Shizuo Akira, Klaus Pfeffer, Gottfried Alber, Matthias Lochner, Irmgard Förster, Oliver Liesenfeld.   

Abstract

Oral infection of C57BL/6 mice with Toxoplasma gondii results in small intestinal Th1-type immunopathology mediated by local production of IFN-gamma, TNF-alpha, and NO. To analyze whether the proinflammatory cytokines IL-12 and IL-18 play a role in the induction of immunopathology, IL-12p35/p40(-/-) and IL-18(-/-) mice were orally infected with T. gondii. Wild-type mice developed massive necrosis in their small intestines and died 7-10 days post infection. Even though IL-12p35/40(-/-) mice did not develop the necrosis they all died between day 9 and 11 after infection. In contrast, 50% of IL-18(-/-) mice died during the acute phase of infection. Compared to wild-type mice, IL-12p35/p40(-/-) but not IL-18(-/-) mice showed significantly higher parasite numbers in their small intestines and significantly higher numbers of parasite-associated inflammatory foci in their livers. IFN-gamma production was similar in infected wild-type and IL-18(-/-) mice but significantly decreased in IL-12p35/p40(-/-) mice. Treatment of mice with anti-IL-12- or anti-IL-18 antibodies after infection prevented the development of intestinal necrosis. These results reveal that both IL-12 and IL-18 play an important role in the development of intestinal immunopathology following oral infection with T. gondii. However, IL-12 is dominant over IL-18 in the host defense against parasite replication. Therefore, neutralization of IL-18 (rather than TNF-alpha, IL-12, and IFN-gamma) may be a safe strategy for the treatment of Th1-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368276     DOI: 10.1002/eji.200424993

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  39 in total

1.  Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18.

Authors:  D Struck; I Frank; S Enders; U Steinhoff; C Schmidt; A Stallmach; O Liesenfeld; M M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 2.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

3.  NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.

Authors:  Crescent L Combe; Tyler J Curiel; Magali M Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 5.  IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Authors:  Govardhana Rao Yannam; Tanuja Gutti; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-24       Impact factor: 4.147

6.  Intraepithelial lymphocytes, goblet cells and VIP-IR submucosal neurons of jejunum rats infected with Toxoplasma gondii.

Authors:  Débora M G Sant'Ana; Marcelo B Góis; Jacqueline N Zanoni; Aristeu V da Silva; Cleverton J T da Silva; Eduardo J A Araújo
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

7.  Do you see what I see: Recognition of protozoan parasites by Toll-like receptors.

Authors:  Debopam Ghosh; Jason S Stumhofer
Journal:  Curr Immunol Rev       Date:  2013-08

8.  Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

Authors:  Melba Muñoz; Markus M Heimesaat; Kerstin Danker; Daniela Struck; Uwe Lohmann; Rita Plickert; Stefan Bereswill; André Fischer; Ildikò Rita Dunay; Kerstin Wolk; Christoph Loddenkemper; Hans-Willi Krell; Claude Libert; Leif R Lund; Oliver Frey; Christoph Hölscher; Yoichiro Iwakura; Nico Ghilardi; Wenjun Ouyang; Thomas Kamradt; Robert Sabat; Oliver Liesenfeld
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

9.  Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.

Authors:  Stefan Bereswill; Melba Muñoz; André Fischer; Rita Plickert; Lea-Maxie Haag; Bettina Otto; Anja A Kühl; Christoph Loddenkemper; Ulf B Göbel; Markus M Heimesaat
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

10.  Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis.

Authors:  S Bereswill; A Fischer; I R Dunay; A A Kühl; U B Göbel; O Liesenfeld; M M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.